Toll-Like Receptor 4 Signalling and Its Impact on Platelet Function, Thrombosis, and Haemostasis

Mediators of Inflammation

Volumn 2017, Issue , 2017, Pages

  Vallance, Thomas M ^a   Zeuner, Marie Theres ^a   Williams, Harry F ^a   Widera, Darius ^a   Vaiyapuri, Sakthivel ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4;

BLOOD VESSEL INJURY; CELL MEMBRANE; HEMOSTASIS; HUMAN; INNATE IMMUNITY; LEUKOCYTE; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOSIS; ANIMAL; METABOLISM; PHYSIOLOGY; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; HEMOSTASIS; HUMANS; SIGNAL TRANSDUCTION; THROMBOSIS; TOLL-LIKE RECEPTOR 4;

EID: 85042589594     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2017/9605894     Document Type: Review

References (101)

1. P. Von Hundelshausen and C. Weber, "Platelets as immune cells: bridging inflammation and cardiovascular disease," Circulation Research, vol. 100, no. 1, pp. 27-40, 2007.
2. J. Berthet, P. Damien, H. Hamzeh-Cognasse, B. Pozzetto, O. Garraud, and F. Cognasse, "Toll-like receptor 4 signal transduction in platelets: novel pathways," British Journal of Haematology, vol. 151, no. 1, pp. 89-92, 2010.
3. A. A. Alhasan, O. G. Izuogu, H. H. Al-Balool et al., "Circular RNA enrichment in platelets is a signature of transcriptome degradation," Blood, vol. 127, no. 9, pp. e1-e11, 2016.
4. K. Jurk and B. E. Kehrel, "Platelets: physiology and biochemistry," Seminars in Thrombosis and Haemostasis, vol. 31, no. 4, pp. 381-392, 2005.
5. S. Offermanns, "Activation of platelet function through G protein-coupled receptors," Circulation Research, vol. 99, no. 12, pp. 1293-1304, 2006.
6. C. Deppermann and P. Kubes, "Platelets and infection," Seminars in Immunology, vol. 28, no. 6, pp. 536-545, 2016.
7. N. Mackman, "Triggers, targets and treatments for thrombosis," Nature, vol. 451, no. 7181, pp. 914-918, 2008.
8. K. M. Gurses, D. Kocyigit, M. U. Yalcin et al., "Enhanced platelet Toll-like receptor 2 and 4 expression in acute coronary syndrome and stable angina pectoris," The American Journal of Cardiology, vol. 116, no. 11, pp. 1666-1671, 2015.
9. P. Prakash, P. P. Kulkarni, S. R. Lentz, and A. K. Chauhan, "Cellular fibronectin containing extra domain A promotes arterial thrombosis in mice through platelet Toll-like receptor 4," Blood, vol. 125, no. 20, pp. 3164-3172, 2015.
10. P. Libby, "Inflammation in atherosclerosis," Nature, vol. 420, no. 6917, pp. 868-874, 2002.
11. L. M. Beaulieu and J. E. Freedman, "The role of inflammation in regulating platelet production and function: Toll-like receptors in platelets and megakaryocytes," Thrombosis Research, vol. 125, no. 3, pp. 205-209, 2010.
12. F. Cognasse, K. A. Nguyen, P. Damien et al., "The inflammatory role of platelets via their TLRs and Siglec receptors," Frontiers in Immunology, vol. 6, no. 83, pp. 1-15, 2015.
13. M. Arman, K. Krauel, D. O. Tilley et al., "Amplification of bacteria-induced platelet activation is triggered by FcγRIIA, integrin αIIbβ3, and platelet factor 4," Blood, vol. 123, no. 20, pp. 3166-3174, 2014.
14. A. L. Ståhl, M. Svensson, M. Mörgelin et al., "Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome," Blood, vol. 108, no. 1, pp. 167-176, 2006.
15. T. Youssefian, A. Drouin, J. M. Massé, J. Guichard, and E. M. Cramer, "Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation," Blood, vol. 99, no. 11, pp. 4021-4029, 2002.
16. J. W. Semple, R. Aslam, M. Kim, E. R. Speck, and J. Freedman, "Platelet-bound lipopolysaccharide enhances Fc receptor-mediated phagocytosis of IgG-opsonized platelets," Blood, vol. 109, no. 11, pp. 4803-4805, 2007.
17. I. C. Macaulay, P. Carr, A. Gusnanto, W. H. Ouwehand, D. Fitzgerald, and N. A. Watkins, "Platelet genomics and proteomics in human health and disease," Journal of Clinical Investigation, vol. 115, no. 12, pp. 3370-3377, 2005.
18. R. J. Stark, N. Aghakasiri, and R. E. Rumbaut, "Plateletderived Toll-like receptor 4 (TLR-4) is sufficient to promote microvascular thrombosis in endotoxemia," PLoS One, vol. 7, no. 7, article e41254, 2012.
19. R. P. Davis, S. Miller-Dorey, and C. N. Jenne, "Platelets and coagulation in infection," Clinical &Translational Immunology, vol. 5, no. 7, article e89, 2016.
20. M. Levi and T. van der Poll, "Coagulation and sepsis," Thrombosis Research, vol. 149, pp. 38-44, 2017.
21. J. L. Chin, S. H. Hisamuddin, A. O'Sullivan, G. Chan, and P. A. McCormick, "Thrombocytopenia, platelet transfusion, and outcome following liver transplantation," Clinical and Applied Thrombosis/Hemostasis, vol. 22, no. 4, pp. 351-360, 2016.
22. S. R. Clark, A. C. Ma, S. A. Tavener et al., "Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood," Nature Medicine, vol. 13, no. 4, pp. 463-469, 2007.
23. M. Zeuner, K. Bieback, and D. Widera, "Controversial role of Toll-like receptor 4 in adult stem cells," Stem Cell Reviews and Reports, vol. 11, no. 4, pp. 621-634, 2015.
24. A. F. McGettrick and L. A. O'Neill, "Localisation and trafficking of Toll-like receptors: an important mode of regulation," Current Opinion in Immunology, vol. 22, no. 1, pp. 20-27, 2010.
25. Z. A. Karim, H. P. Vemana, and F. T. Khasawneh, "MALT1-ubiquitination triggers non-genomic NF-kB/IKK signaling upon platelet activation," PLoS One, vol. 10, no. 3, article e0119363, 2015.
26. L. Rivadeneyra, A. Carestia, J. Etulain et al., "Regulation of platelet responses triggered by Toll-like receptor 2 and 4 ligands is another non-genomic role of nuclear factorkappaB," Thrombosis Research, vol. 133, no. 2, pp. 235-243, 2014.
27. U. Ohto, K. Fukase, K. Miyake, and T. Shimizu, "Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2," Proceedings of the National Academy of Sciences, vol. 109, no. 19, pp. 7421-7426, 2012.
28. J. A. Gegner, R. J. Ulevitch, and P. S. Tobias, "Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14," Journal of Biological Chemistry, vol. 270, no. 10, pp. 5320-5325, 1995.
29. A. Steimle, I. B. Autenrieth, and J. S. Frick, "Structure and function: lipid A modifications in commensals and pathogens," International Journal of Medical Microbiology, vol. 306, no. 5, pp. 290-301, 2016.
30. F. Cognasse, H. Hamzeh-Cognasse, S. Lafarge et al., "Toll-like receptor 4 ligand can differentially modulate the release of cytokines by human platelets," British Journal of Haematology, vol. 141, no. 1, pp. 84-91, 2008.
31. J. M. Billod, A. Lacetera, J. Guzmán-Caldentey, and S. Martín-Santamaría, "Computational approaches to Tolllike receptor 4 modulation," Molecules, vol. 21, no. 8, p. 994, 2016.
32. S. Vogel, R. Bodenstein, Q. Chen et al., "Platelet-derived HMGB1 is a critical mediator of thrombosis," Journal of Clinical Investigation, vol. 125, no. 12, pp. 4638-4654, 2015.
33. Q. Yin, T. M. Fu, J. Li, and H. Wu, "Structural biology of innate immunity," Annual Review of Immunology, vol. 33, pp. 393-416, 2015.
34. G. A. Esparza, A. Teghanemt, D. Zhang, T. L. Gioannini, and J. P. Weiss, "Endotoxin.albumin complexes transfer endotoxin monomers to MD-2 resulting in activation of TLR4," Innate Immunity, vol. 18, no. 3, pp. 478-491, 2012.
35. T. L. Gioannini, D. Zhang, A. Teghanemt, and J. P. Weiss, "An essential role for albumin in the interaction of endotoxin with lipopolysaccharide-binding protein and sCD14 and resultant cell activation," Journal of Biological Chemistry, vol. 277, no. 49, pp. 47818-47825, 2002.
36. G. Andonegui, S. Kerfoot, K. McNagny, K. Ebbert, K. Patel, and P. Kubes, "Platelets express functional Toll-like receptor-4 (TLR4)," Blood, vol. 106, no. 7, pp. 2417-2423, 2005.
37. B. S. Park, D. H. Song, H. M. Kim, B. S. Choi, H. Lee, and J. O. Lee, "The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex," Nature, vol. 458, no. 7242, pp. 1191-1195, 2009.
38. Y. Nagai, S. Akashi, M. Nagafuku et al., "Essential role of MD-2 in LPS responsiveness and TLR4 distribution," Nature Immunology, vol. 3, no. 7, pp. 667-672, 2002.
39. R. Shimazu, S. Akashi, H. Ogata et al., "MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4," The Journal of Experimental Medicine, vol. 189, no. 11, pp. 1777-1782, 1999.
40. M. Pascual-Lucas, S. Fernandez-Lizarbe, J. Montesinos, and C. Guerri, "LPS or ethanol triggers clathrin-and rafts/caveolae-dependent endocytosis of TLR4 in cortical astrocytes," Journal of Neurochemistry, vol. 129, no. 3, pp. 448-462, 2014.
41. F. Cognasse, H. Hamzeh, P. Chavarin, S. Acquart, C. Genin, and O. Garraud, "Evidence of Toll-like receptor molecules on human platelets," Immunology and Cell Biology, vol. 83, no. 2, pp. 196-198, 2005.
42. R. Aslam, E. R. Speck, M. Kim et al., "Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-α production in vivo," Blood, vol. 107, no. 2, pp. 637-642, 2006.
43. J. C. Kagan, T. Su, T. Horng, A. Chow, S. Akira, and R. Medzhitov, "TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β," Nature Immunology, vol. 9, no. 4, pp. 361-368, 2008.
44. E. M. Moresco, D. LaVine, and B. Beutler, "Toll-like receptors," Current Biology, vol. 21, no. 13, pp. R488-R493, 2011.
45. F. Randow and B. Seed, "Endoplasmic reticulum chaperone gp96 is required for innate immunity but not cell viability," Nature Cell Biology, vol. 3, no. 10, pp. 891-896, 2001.
46. J. C. Kagan and R. Medzhitov, "Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling," Cell, vol. 125, pp. 943-955, 2006.
47. S. C. Lin, Y. C. Lo, and H. Wu, "Helical assembly in the MyD88:IRAK4:IRAK2 complex in TLR/IL-1R signalling," Nature, vol. 465, no. 7300, pp. 885-890, 2010.
48. H. Hacker, P. H. Tseng, and M. Karin, "Expanding TRAF function: TRAF3 as a tri-faced immune regulator," Nature Reviews Immunology, vol. 11, no. 7, pp. 457-468, 2011.
49. A. Plóciennikowska, A. Hromada-Judycka, K. Borzecka, and K. Kwiatkowska, "Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling," Cellular and Molecular Life Sciences, vol. 72, no. 3, pp. 557-581, 2015.
50. M. T. Zeuner, C. L. Kruger, K. Volk et al., "Biased signalling is an essential feature of TLR4 in glioma cells," Biochimica et Biophysica Acta, vol. 1863, no. 12, pp. 3084-3095, 2016.
51. T. Kawai and S. Akira, "Signaling to NF-kB by Toll-like receptors," Trends in Molecular Medicine, vol. 13, no. 11, pp. 460-469, 2007.
52. H. Husebye, \O. Halaas, H. Stenmark et al., "Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity," The EMBO Journal, vol. 25, no. 4, pp. 683-692, 2006.
53. N. Tanimura, S. Saitoh, F. Matsumoto, S. Akashi-Takamura, and K. Miyake, "Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling," Biochemical and Biophysical Research Communications, vol. 368, no. 1, pp. 94-99, 2008.
54. E. Latz, A. Visintin, E. Lien et al., "Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the Tolllike receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction," Journal of Biological Chemistry, vol. 277, no. 49, pp. 47834-47843, 2002.
55. I. Zanoni, R. Ostuni, L. R. Marek et al., "CD14 controls the LPS-induced endocytosis of Toll-like receptor 4," Cell, vol. 147, no. 4, pp. 868-880, 2011.
56. Z. Jiang, P. Georgel, X. Du et al., "CD14 is required for MyD88-independent LPS signaling," Nature Immunology, vol. 6, no. 6, pp. 565-570, 2005.
57. Z. Sun, "Platelet TLR4: A critical link in pulmonary arterial hypertension," Circulation Research, vol. 114, no. 10, pp. 1551-1553, 2014.
58. J. D. McFadyen and Z. S. Kaplan, "Platelets are not just for clots," Transfusion Medicine Reviews, vol. 29, no. 2, pp. 110-119, 2015.
59. J. M. Gibbins, "Platelet adhesion signalling and the regulation of thrombus formation," Journal of Cell Science, vol. 117, no. 16, pp. 3415-3425, 2004.
60. B. Nieswandt, D. Varga-Szabo, and M. Elvers, "Integrins in platelet activation," Journal of Thrombosis and Haemostasis, vol. 7, Supplement 1, pp. 206-209, 2009.
61. G. Zhang, J. Han, E. J. Welch et al., "LPS stimulates platelet secretion and potentiates platelet aggregation via TLR4/ MyD88 and the cGMP-dependent protein kinase pathway," The Journal of Immunology, vol. 182, no. 12, pp. 7997-8004, 2009.
62. K. Hashimoto, M. Jayachandran, W. G. Owen, and V. M. Miller, "Aggregation and microparticle production through Toll-like receptor 4 activation in platelets from recently menopausal women," Journal of Cardiovascular Pharmacology, vol. 54, no. 1, pp. 57-62, 2009.
63. P. N. Shashkin, G. T. Brown, A. Ghosh, G. K. Marathe, and T. M. McIntyre, "Lipopolysaccharide is a direct agonist for platelet RNA splicing," The Journal of Immunology, vol. 181, no. 5, pp. 3495-3502, 2008.
64. F. Liu, S. A. Morris, J. L. Epps, and R. C. Carroll, "Demonstration of an activation regulated NF-kappaB/I-kappaBalpha complex in human platelets," Thrombosis Research, vol. 106, no. 4-5, pp. 199-203, 2002.
65. G. T. Brown and T. M. McIntyre, "Lipopolysaccharide signaling without a nucleus: kinase cascades stimulate platelet shedding of proinflammatory IL-1β-rich microparticles," The Journal of Immunology, vol. 186, no. 9, pp. 5489-5496, 2011.
66. J. Berthet, P. Damien, H. Hamzeh-Cognasse et al., "Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion," Clinical Immunology, vol. 145, no. 3, pp. 189-200, 2012.
67. P. Damien, F. Cognasse, M.-A. Eyraud et al., "LPS stimulation of purified human platelets is partly dependent on plasma soluble CD14 to secrete their main secreted product, soluble-CD40-ligand," BMC Immunology, vol. 16, p. 3, 2015.
68. F. Cognasse, S. Lafarge, P. Chavarin, S. Acquart, and O. Garraud, "Lipopolysaccharide induces sCD40L release through human platelets TLR4, but not TLR2 and TLR9," Intensive Care Medicine, vol. 33, no. 2, pp. 382-384, 2007.
69. A. Assinger, M. Laky, S. Badrnya, A. Esfandeyari, and I. Volf, "Periodontopathogens induce expression of CD40L on human platelets via TLR2 and TLR4," Thrombosis Research, vol. 130, no. 3, pp. e73-e78, 2012.
70. P. André, L. Nannizzi-Alaimo, S. K. Prasad, and D. R. Phillips, "Platelet-derived CD40L: the switch-hitting player of cardiovascular disease," Circulation, vol. 106, no. 8, pp. 896-899, 2002.
71. S. F. de Stoppelaar, T. A. Claushuis, M. P. Jansen et al., "The role of platelet MyD88 in host response during gram-negative sepsis," Journal of Thrombosis and Haemostasis, vol. 13, no. 9, pp. 1709-1720, 2015.
72. M. M. Denis, N. D. Tolley, M. Bunting et al., "Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets," Cell, vol. 122, pp. 379-391, 2005.
73. Z. A. Karim, J. Zhang, M. Banerjee et al., "IkB kinase phosphorylation of SNAP-23 controls platelet secretion," Blood, vol. 121, no. 22, pp. 4567-4574, 2013.
74. E. Malaver, M. A. Romaniuk, L. P. D'atri et al., "NF-kB inhibitors impair platelet activation responses," Journal of Thrombosis and Haemostasis, vol. 7, no. 8, pp. 1333-1343, 2009.
75. Z. Li, X. Xi, M. Gu et al., "A stimulatory role for cGMPdependent protein kinase in platelet activation," Cell, vol. 112, no. 1, pp. 77-86, 2003.
76. Z. Li, G. Zhang, J. A. Marjanovic, C. Ruan, and X. Du, "A platelet secretion pathway mediated by cGMP-dependent protein kinase," Journal of Biological Chemistry, vol. 279, no. 41, pp. 42469-42475, 2004.
77. J. R. Ward, L. Bingle, H. M. Judge et al., "Agonists of Toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor," Thrombosis and Haemostasis, vol. 94, no. 4, pp. 831-838, 2005.
78. S. F. de Stoppelaar, T. A. M. Claushuis, M. C. Schaap et al., "Toll-like receptor signalling is not involved in platelet response to Streptococcus pneumoniae in vitro or in vivo," PLoS One, vol. 11, no. 6, article e0156977, 2016.
79. S. W. Kerrigan and D. Cox, "Platelet-bacterial interactions," Cellular and Molecular Life Sciences, vol. 67, no. 4, pp. 513-523, 2010.
80. S. L. Spinelli, A. E. Casey, S. J. Pollock et al., "Platelets and megakaryocytes contain functional nuclear factor-kB," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 3, pp. 591-598, 2010.
81. F. Semeraro, C. T. Ammollo, J. H. Morrissey et al., "Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4," Blood, vol. 118, no. 7, pp. 1952-1961, 2011.
82. M. Zeuner, T. Vallance, S. Vaiyapuri, G. S. Cottrell, and D. Widera, "Development and characterisation of a novel NF-kB reporter cell line for investigation of neuroinflammation," Mediators of Inflammation, vol. 2017, Article ID 6209865, 2017.
83. I. Mitroulis, K. Kambas, A. Chrysanthopoulou et al., "Neutrophil extracellular trap formation is associated with IL-1β and autophagy-related signaling in gout," PLoS One, vol. 6, no. 12, article e29318, 2011.
84. L. X. Yu, L. Yan, W. Yang et al., "Platelets promote tumour metastasis via interaction between TLR4 and tumour cellreleased high-mobility group box1 protein," Nature Communications, vol. 5, p. 5256, 2014.
85. L. J. Gay and B. Felding-Habermann, "Contribution of platelets to tumour metastasis," Nature Reviews Cancer, vol. 11, no. 2, pp. 123-134, 2011.
86. H. Hreggvidsdottir, T. Ostberg, H. Wähämaa et al., "The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation," Journal of Leukocyte Biology, vol. 86, no. 3, pp. 655-662, 2009.
87. J. H. Youn, Y. J. Oh, E. S. Kim, J. E. Choi, and J. Shin, "High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-α production in human monocytes," The Journal of Immunology, vol. 180, no. 7, pp. 5067-5074, 2008.
88. G. P. Sims, D. C. Rowe, S. T. Rietdijk, R. Herbst, and A. J. Coyle, "HMGB1 and RAGE in inflammation and cancer," Annual Review of Immunology, vol. 28, pp. 367-388, 2010.
89. J. Westman, P. Papareddy, M. W. Dahlgren et al., "Extracellular histones induce chemokine production in whole blood ex vivo and leukocyte recruitment in vivo," PLoS Pathogens, vol. 11, no. 12, article e1005319, 2015.
90. J. Xu, X. Zhang, M. Monestier, N. L. Esmon, and C. T. Esmon, "Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury," The Journal of Immunology, vol. 187, no. 5, pp. 2626-2631, 2011.
91. J. Xu, X. Zhang, R. Pelayo et al., "Extracellular histones are major mediators of death in sepsis," Nature Medicine, vol. 15, no. 11, pp. 1318-1321, 2009.
92. C. T. Esmon, "Extracellular histones zap platelets," Blood, vol. 118, no. 13, pp. 3456-3457, 2011.
93. T. A. Fuchs, A. A. Bhandari, and D. D. Wagner, "Histones induce rapid and profound thrombocytopenia in mice," Blood, vol. 118, no. 13, pp. 3708-3714, 2011.
94. Y. Zhao, C. Zhang, X. Wei et al., "Heat shock protein 60 stimulates the migration of vascular smooth muscle cells via Toll-like receptor 4 and ERK MAPK activation," Scientific Reports, vol. 5, no. 1, article 15352, 2015.
95. B. Hochleitner, E. Hochleitner, P. Obrist et al., "Fluid shear stress induces heat shock protein 60 expression in endothelial cells in vitro and in vivo," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, pp. 617-623, 2000.
96. R. Ebert, P. Benisch, M. Krug et al., "Acute phase serum amyloid A induces proinflammatory cytokines and mineralization via Toll-like receptor 4 in mesenchymal stem cells," Stem Cell Research, vol. 15, no. 1, pp. 231-239, 2015.
97. S. Urieli-Shoval, G. Shubinsky, R. P. Linke, M. Fridkin, I. Tabi, and Y. Matzner, "Adhesion of human platelets to serum amyloid A," Blood, vol. 99, no. 4, pp. 1224-1229, 2002.
98. E. M. Bauer, R. S. Chanthaphavong, C. P. Sodhi, D. J. Hackam, T. R. Billiar, and P. M. Bauer, "Genetic deletion of Toll-like receptor 4 on platelets attenuates experimental pulmonary hypertension," Circulation Research, vol. 114, no. 10, pp. 1596-1600, 2014.
99. N. Ding, G. Chen, R. Hoffman et al., "TLR4 regulates platelet function and contributes to coagulation abnormality and organ injury in hemorrhagic shock and resuscitation," Circulation: Cardiovascular Genetics, vol. 7, no. 5, pp. 615-624, 2014.
100. P. Patrignani, C. Di Febbo, S. Tacconelli et al., "Reduced thromboxane biosynthesis in carriers of Toll-like receptor 4 polymorphisms in vivo," Blood, vol. 107, no. 9, pp. 3572-3574, 2006.
101. J. C. Tsai, Y. W. Lin, C. Y. Huang, F. Y. Lin, and C. S. Tsai, "Calpain activity and Toll-like receptor 4 expression in platelet regulate haemostatic situation in patients undergoing cardiac surgery and coagulation in mice," Mediators of Inflammation, vol. 2014, Article ID 484510, 12 pages, 2014.